Complementary Therapies of Diabetic Peripheral Neuropathy and Intermittent Claudication. [PDF]
Ng SY.
europepmc +1 more source
Early ambulation and dhikr complementary therapies effect on intestinal peristaltic in post-open cholecystectomy patients. [PDF]
Wilandika A, Gartika N, Nurfarida E.
europepmc +1 more source
Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek +2 more
wiley +1 more source
Scale for Assessing Understanding of Benefits and Risks of Using Complementary Therapies in Diabetes Management: Psychometric Evaluation. [PDF]
Chang HY, Huang YY, Lo CL.
europepmc +1 more source
Effectiveness of Complementary Therapies in Cancer Patients: A Systematic Review. [PDF]
Guerra-Martín MD +2 more
europepmc +1 more source
Complementary and Alternative Medicine (CAM) Therapies in the Treatment of Meniere's Syndrome: Illness Narratives [PDF]
Bennett, T +3 more
core
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley +1 more source
Complementary therapies for the management of attention deficit hyperactivity disorder in children: a scoping review. [PDF]
Szychta LF +5 more
europepmc +1 more source
How best to capture the impact of complementary therapies in palliative care: A systematic review to identify and assess the appropriateness and validity of multi-domain tools. [PDF]
Mitchinson L +8 more
europepmc +1 more source
This work identified serum proteins associated with pancreatic epithelial neoplasms (PanINs) and early‐stage PDAC. Proteomics screens assessed genetically engineered mice with abundant PanINs, KPC mice (Lox‐STOP‐Lox‐KrasG12D/+ Lox‐STOP‐Lox‐Trp53R172H/+ Pdx1‐Cre) before PDAC development and also early‐stage PDAC patients (n = 31), compared to benign ...
Hannah Mearns +10 more
wiley +1 more source

